112 related articles for article (PubMed ID: 8020519)
1. Clinical pharmacology of iomeprol.
Rosati G
Eur J Radiol; 1994 May; 18 Suppl 1():S51-60. PubMed ID: 8020519
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic effects of iomeprol for injection in experimental animals.
Cipolla P; Tirone P; Luzzani F; de Haën C
Eur J Radiol; 1994 May; 18 Suppl 1():S32-42. PubMed ID: 8020517
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility and safety profile of iomeprol.
Rosati G
Eur J Radiol; 1994 May; 18 Suppl 1():S120-4. PubMed ID: 8020514
[TBL] [Abstract][Full Text] [Related]
4. Iomeprol: a review of its use as a contrast medium.
Dooley M; Jarvis B
Drugs; 2000 May; 59(5):1169-86. PubMed ID: 10852647
[TBL] [Abstract][Full Text] [Related]
5. Iomeprol and iopamidol in cardiac angiography: a randomised, double-blind, parallel-group comparison.
Fattori R; Piva R; Schicchi F; Pancrazi A; Gabrielli G; Marzocchi A; Piovaccari G; Blandini A; Magnani B
Eur J Radiol; 1994 May; 18 Suppl 1():S61-6. PubMed ID: 8020520
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with iomeprol in myelography and myelo-CT: clinical pharmacology and double-blind comparisons with iopamidol, iohexol, and iotrolan.
Katayama H; Heneine N; van Gessel R; Taroni P; Spinazzi A
Invest Radiol; 2001 Jan; 36(1):22-32. PubMed ID: 11176258
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis.
Lorusso V; Taroni P; Alvino S; Spinazzi A
Invest Radiol; 2001 Jun; 36(6):309-16. PubMed ID: 11410750
[TBL] [Abstract][Full Text] [Related]
8. Effects of dimeric radiographic contrast medium iotrolan on Swine renal arteries: comparison with monomeric contrast media iohexol and iomeprol.
Heinrich M; Schneider G; Grgic A; Humke U; Kramann B; Uder M
Invest Radiol; 2004 Jul; 39(7):406-12. PubMed ID: 15194911
[TBL] [Abstract][Full Text] [Related]
9. Effect of acute renal failure on the distribution of iomeprol, a nonionic contrast agent, to cerebrospinal fluid in rats.
Hagino M; Yamamoto K; Ohashi K; Sueda T; Kotaki H; Hayashi M; Sawada Y; Iga T
Biol Pharm Bull; 1997 Aug; 20(8):939-42. PubMed ID: 9300148
[TBL] [Abstract][Full Text] [Related]
10. Effects of iomeprol, a new nonionic contrast medium, vis a vis iopamidol and nitroglycerin, on coronary diameter and blood flow in chronically instrumented dogs.
Narishige T; Egashira K; Akatsuka Y; Takahashi T; Takeshita A
Cardiovasc Intervent Radiol; 1993; 16(6):343-7. PubMed ID: 8131164
[TBL] [Abstract][Full Text] [Related]
11. Preclinical safety assessment of iomeprol for injection as contrast medium for myelography.
La Noce A; Bertani F; Lorusso V; Luzzani F; Tirone P; de Haën C
Eur J Radiol; 1994 May; 18 Suppl 1():S43-50. PubMed ID: 8020518
[TBL] [Abstract][Full Text] [Related]
12. Iomeprol versus iopamidol in contrast-enhanced computed tomography of thoracic and abdominal organs.
Valentini AL; Tartaglione T; Monti L; Marano P
Eur J Radiol; 1994 May; 18 Suppl 1():S88-92. PubMed ID: 8020525
[TBL] [Abstract][Full Text] [Related]
13. New non-ionic contrast: effects on the cardiovascular system.
Pagny JY; Gaux JC
Eur J Radiol; 1996 Nov; 23 Suppl 1():S2-5. PubMed ID: 9056156
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tissue distribution of iomeprol in animals.
Lorusso V; Luzzani F; Bertani F; Tirone P; de Haën C
Eur J Radiol; 1994 May; 18 Suppl 1():S13-20. PubMed ID: 8020515
[TBL] [Abstract][Full Text] [Related]
15. Iomeprol: current and future profile of a radiocontrast agent.
Katayama H; Spinazzi A; Fouillet X; Kirchin MA; Taroni P; Davies A
Invest Radiol; 2001 Feb; 36(2):87-96. PubMed ID: 11224756
[TBL] [Abstract][Full Text] [Related]
16. Effect of iomeprol on rat hippocampal slice synaptic transmission: comparison with other X-ray contrast agents.
Frigeni V; Samuelli G; Miragoli L; Grotti A; Lorusso V
Invest Radiol; 2002 Apr; 37(4):222-31. PubMed ID: 11923645
[TBL] [Abstract][Full Text] [Related]
17. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
[TBL] [Abstract][Full Text] [Related]
18. A double-blind comparative study of the safety and efficacy of iomeprol in renal intra-arterial digital subtraction angiography.
Simonetti G; Guazzaroni M; Carpanese L; Canalis GC; Urigo F
Eur J Radiol; 1994 May; 18 Suppl 1():S73-6. PubMed ID: 8020522
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the contrast density of iomeprol.
Schmiedel E
Eur J Radiol; 1994 May; 18 Suppl 1():S97-103. PubMed ID: 8020527
[TBL] [Abstract][Full Text] [Related]
20. Elimination of iomeprol by hemodialysis.
Ueda J; Furukawa T; Higashino K; Takahashi S; Araki Y; Sakaguchi K
Eur J Radiol; 1996 Nov; 23(3):197-200. PubMed ID: 9003924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
